Taiwan launches NT$10B fund to back biotech commercialization

<p class="P1" data-sourcepos="5:1-5:412;98-509">Taiwan's National Development Fund Management Committee on the 4th approved a new NT$10 billion (US$308 million) investment program for the country's biomedical industry. The 10-year initiative aims to support firms with innovative technology, strong clinical application value and international market potential, as the government looks to link Taiwan's biotech sector more closely with global markets.